A detailed history of Nebula Research & Development LLC transactions in Enovis Corp stock. As of the latest transaction made, Nebula Research & Development LLC holds 17,982 shares of ENOV stock, worth $839,219. This represents 0.09% of its overall portfolio holdings.

Number of Shares
17,982
Previous 7,909 127.36%
Holding current value
$839,219
Previous $357 Million 116.55%
% of portfolio
0.09%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$40.57 - $48.1 $408,661 - $484,511
10,073 Added 127.36%
17,982 $774 Million
Q2 2024

Aug 14, 2024

SELL
$44.56 - $62.43 $511,326 - $716,384
-11,475 Reduced 59.2%
7,909 $357 Million
Q1 2024

May 15, 2024

BUY
$55.44 - $63.8 $1.07 Million - $1.24 Million
19,384 New
19,384 $1.21 Billion
Q3 2023

Nov 14, 2023

BUY
$51.65 - $65.54 $359,432 - $456,092
6,959 New
6,959 $367 Million

Others Institutions Holding ENOV

About Enovis CORP


  • Ticker ENOV
  • Exchange NYSE
  • Sector Industrials
  • Industry Specialty Industrial Machinery
  • Shares Outstandng 54,129,500
  • Market Cap $2.53B
  • Description
  • Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...
More about ENOV
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.